XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021   217,117      
Beginning balance at Dec. 31, 2021 $ 6,381,689 $ 2 $ 2,034,658 $ (3,395) $ 4,350,424
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)   2,240      
Issuance of common stock upon exercise of stock options, net of repurchases 34,942   34,942    
Stock-based compensation expense 815,094   815,094    
Issuance of equity instruments as consideration for business combination (in shares)   1,663      
Issuance of equity instruments as consideration for business combination 314,356   314,356    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)   3,223      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (213,133)   (213,133)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)   155      
Issuance of common stock under the Employee Stock Purchase Plan (the “ESPP”) 14,863   14,863    
Other 3,679   3,679    
Comprehensive loss (14,788)     (14,788)  
Net loss (1,523,313)       (1,523,313)
Ending balance (in shares) at Jun. 30, 2022   224,398      
Ending balance at Jun. 30, 2022 5,813,389 $ 2 3,004,459 (18,183) 2,827,111
Beginning balance (in shares) at Mar. 31, 2022   221,325      
Beginning balance at Mar. 31, 2022 6,496,093 $ 2 2,579,216 (3,890) 3,920,765
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)   1,115      
Issuance of common stock upon exercise of stock options, net of repurchases 16,446   16,446    
Stock-based compensation expense 461,556   461,556    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)   1,803      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (71,301)   (71,301)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)   155      
Issuance of common stock under the Employee Stock Purchase Plan (the “ESPP”) 14,863   14,863    
Other 3,679   3,679    
Comprehensive loss (14,293)     (14,293)  
Net loss (1,093,654)       (1,093,654)
Ending balance (in shares) at Jun. 30, 2022   224,398      
Ending balance at Jun. 30, 2022 5,813,389 $ 2 3,004,459 (18,183) 2,827,111
Beginning balance (in shares) at Dec. 31, 2022   230,866      
Beginning balance at Dec. 31, 2022 $ 5,454,557 $ 2 3,767,686 (38,606) 1,725,475
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of repurchases (in shares) 1,203 1,180      
Issuance of common stock upon exercise of stock options, net of repurchases $ 18,001   18,001    
Stock-based compensation expense 427,606   427,606    
Issuance of equity instruments as consideration for business combination (in shares)   961      
Issuance of equity instruments as consideration for business combination 44,995   44,995    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)   3,627      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (115,392)   (115,392)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)   254      
Issuance of common stock under the Employee Stock Purchase Plan (the “ESPP”) 12,381   12,381    
Stock-based compensation expense recognized in relation to restructuring 84,042   84,042    
Comprehensive loss 4,814     4,814  
Net loss (176,301)       (176,301)
Ending balance (in shares) at Jun. 30, 2023   236,888      
Ending balance at Jun. 30, 2023 5,754,703 $ 2 4,239,319 (33,792) 1,549,174
Beginning balance (in shares) at Mar. 31, 2023   234,495      
Beginning balance at Mar. 31, 2023 5,674,946 $ 2 4,056,774 (28,409) 1,646,579
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)   467      
Issuance of common stock upon exercise of stock options, net of repurchases 8,435   8,435    
Stock-based compensation expense 214,624   214,624    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)   1,672      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (52,895)   (52,895)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)   254      
Issuance of common stock under the Employee Stock Purchase Plan (the “ESPP”) 12,381   12,381    
Comprehensive loss (5,383)     (5,383)  
Net loss (97,405)       (97,405)
Ending balance (in shares) at Jun. 30, 2023   236,888      
Ending balance at Jun. 30, 2023 $ 5,754,703 $ 2 $ 4,239,319 $ (33,792) $ 1,549,174